Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0034693,
umls-concept:C0079281,
umls-concept:C0079284,
umls-concept:C0205263,
umls-concept:C0205265,
umls-concept:C0205421,
umls-concept:C0231491,
umls-concept:C0232105,
umls-concept:C0234421,
umls-concept:C0379142,
umls-concept:C0597357,
umls-concept:C0871261,
umls-concept:C1280500,
umls-concept:C1555582,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1801960,
umls-concept:C2911692
|
pubmed:issue |
1
|
pubmed:dateCreated |
1993-10-7
|
pubmed:abstractText |
The ETA receptor antagonist, BQ 123 was used to characterize depressor and initial and delayed pressor responses to ET-1 in conscious rats. BQ 123 (0.001-0.01 mumol/kg/min) dose-dependently inhibited the initial ET-1 (0.1 nmol/kg) pressor response, reaching a maximum after 0.01 BQ 123 (61 +/- 4% inhibition). Less inhibition of the pressor effects occurred after higher doses of BQ 123 (1: 10 +/- 6% inhibition). The depressor response to 1 nmol/kg ET-1 was unchanged by BQ 123 (0.01), but inhibited by BQ 123 (1). The initial pressor response to 1.0 nmol/kg ET-1 was inhibited by BQ 123 (0.01: 26 +/- 6%; 1.0: 41 +/- 3% inhibition). The delayed pressor response, 180 min post-ET-1 (+41 +/- 2% increase) was reduced by BQ 123 infused before the delayed peak (+14 +/- 5% increase). Plasma immunoreactive ET values were: control: 5.4 +/- 0.4; initial peak: 491.4 +/- 50.6; delayed peak: 8.2 +/- 0.6 fmol/ml. The delayed ET-1 response does not coincide with sustained high circulating levels of immunoreactive ET, but inhibition of the response by BQ 123 suggests that it may involve endothelin receptors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Endothelins,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides, Cyclic,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Endothelin A,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Endothelin,
http://linkedlifedata.com/resource/pubmed/chemical/cyclo(Trp-Asp-Pro-Val-Leu)
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0160-2446
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
69-73
|
pubmed:dateRevised |
2004-1-20
|
pubmed:meshHeading |
pubmed-meshheading:7690099-Animals,
pubmed-meshheading:7690099-Blood Pressure,
pubmed-meshheading:7690099-Endothelins,
pubmed-meshheading:7690099-Infusions, Intravenous,
pubmed-meshheading:7690099-Male,
pubmed-meshheading:7690099-Peptides, Cyclic,
pubmed-meshheading:7690099-Rats,
pubmed-meshheading:7690099-Rats, Sprague-Dawley,
pubmed-meshheading:7690099-Receptor, Endothelin A,
pubmed-meshheading:7690099-Receptors, Endothelin,
pubmed-meshheading:7690099-Reference Values,
pubmed-meshheading:7690099-Time Factors
|
pubmed:year |
1993
|
pubmed:articleTitle |
Effects of the endothelin (ET) receptor antagonist BQ 123 on initial and delayed vascular responses induced by ET-1 in conscious, normotensive rats.
|
pubmed:affiliation |
Department of Pharmacology, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543.
|
pubmed:publicationType |
Journal Article
|